Appointment booking for Dr. Charulata Mehta, MD is currently not available.Dr. Charulata Mehta, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Charulata Mehta, MD (she/her) is a Internist in Columbia, MD with over 17 years of experience. What is your opinion of Dr. Charulata Mehta, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 17 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Charulata Mehta, MD has received over $3,008 which includes payments from the following companies:
$802.62 from AbbVie, Inc.
$452.71 from Novo Nordisk Inc
$236.57 from Eisai Inc.
$140.91 from Stryker Corporation
$124.06 from Horizon Pharma plc
$117.85 from US WorldMeds, LLC
$117.25 from AstraZeneca Pharmaceuticals LP
$110.13 from Novartis Pharmaceuticals Corporation
$110.00 from Janssen Pharmaceuticals, Inc
$110.00 from Celgene Corporation
$110.00 from Boehringer Ingelheim Pharmaceuticals, Inc.
$108.71 from Amarin Pharma Inc.
$105.55 from Exactech, Inc.
$95.41 from Sunovion Pharmaceuticals Inc.
$94.33 from LILLY USA, LLC
$86.21 from Salix Pharmaceuticals, Ltd
$55.26 from Purdue Pharma L.P.
$17.05 from GlaxoSmithKline, LLC.
$14.25 from Merck Sharp & Dohme Corporation
Payments received by Dr. Charulata Mehta, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!